Skip to main content
Salyka Sengsayadeth, MD, Oncology, Nashville, TN, Vanderbilt University Medical Center

SalykaSengsayadethMD

Oncology Nashville, TN

Hematologic Oncology

Associate Professor of Medicine, Vanderbilt Univ Sch of Med

Dr. Sengsayadeth is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sengsayadeth's full profile

Already have an account?

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 2006 - 2009
  • East Tennessee State University James H. Quillen College of Medicine
    East Tennessee State University James H. Quillen College of MedicineClass of 2006

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2008 - 2026
  • AL State Medical License
    AL State Medical License 2020 - 2020
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Venetoclax-Based Salvage Therapy for Post-Hematopoietic Cell Transplantation Relapse in Acute Myeloid Leukemia
    Salyka M. Sengsayadeth, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Three-Drug Regimen Improves Protection Against GVHD After Stem Cell Transplant
    Three-Drug Regimen Improves Protection Against GVHD After Stem Cell TransplantJuly 18th, 2023

Hospital Affiliations